HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideki Nakano Selected Research

Dust (House Dust)

1/2022A neutrophil/TGF-β axis limits the pathogenicity of allergen-specific CD4+ T cells.
11/2019Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by a RORγt inverse agonist.
10/2018Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling.
9/2017TNF is required for TLR ligand-mediated but not protease-mediated allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideki Nakano Research Topics

Disease

8Asthma (Bronchial Asthma)
01/2022 - 12/2006
7Inflammation (Inflammations)
01/2022 - 05/2006
5Respiratory Hypersensitivity
01/2021 - 01/2012
4Eosinophilia
01/2022 - 10/2009
3Infections
10/2009 - 01/2005
2Pneumonia (Pneumonitis)
01/2022 - 10/2018
2Dementia (Dementias)
01/2020 - 08/2006
1Paralysis (Palsy)
11/2019
1Hypesthesia (Numbness)
11/2019
1Dyspnea (Shortness of Breath)
03/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2014
1Nausea
06/2014
1Neoplasms (Cancer)
06/2014
1Vomiting
06/2014
1Lipidoses
06/2012
1Arteriovenous Fistula
07/2011
1Mental Disorders (Mental Disorder)
03/2010
1Schizophrenia (Dementia Praecox)
03/2010
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2009
1Virus Diseases (Viral Diseases)
04/2009
1Chorea (Rheumatic Chorea)
01/2009
1Burning Mouth Syndrome (Syndrome, Burning Mouth)
06/2008
1Somatoform Disorders (Somatoform Disorder)
06/2008
1Occupational Stress
04/2008
1Human Influenza (Influenza)
02/2008
1Prion Diseases (Transmissible Spongiform Encephalopathies)
08/2007
1Scrapie
08/2007
1Alzheimer Disease (Alzheimer's Disease)
08/2006
1Granuloma
01/2005
1Sarcoidosis (Schaumann Disease)
01/2005
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2004
1Blindness (Hysterical Blindness)
05/2003
1Pulmonary Hypertension
11/2002
1Respiratory Insufficiency (Respiratory Failure)
09/2002
1Lymphoma (Lymphomas)
07/2002
1Necrosis
07/2002
1Paraplegia (Spastic Paraplegia)
06/2002
1Pleural Effusion (Pleural Effusions)
06/2002

Drug/Important Bio-Agent (IBA)

10AllergensIBA
01/2022 - 05/2006
5LigandsIBA
01/2022 - 05/2006
4Dust (House Dust)FDA Link
01/2022 - 09/2017
3Interleukin-17 (Interleukin 17)IBA
11/2019 - 01/2012
2GlucocorticoidsIBA
01/2021 - 11/2019
2Peptide Hydrolases (Proteases)FDA Link
01/2021 - 09/2017
2OvalbuminIBA
10/2018 - 12/2006
2AntigensIBA
10/2018 - 01/2005
2CytokinesIBA
01/2012 - 04/2008
2CatecholaminesIBA
01/2009 - 04/2008
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2009 - 04/2008
1Uridine Diphosphate (UDP)IBA
01/2021
1Uridine Diphosphate Glucose (UDP Glucose)IBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2019
1Toll-Like Receptor 4IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
09/2017
1Hemoglobins (Hemoglobin)IBA
03/2015
1Aprepitant (Emend)FDA Link
06/2014
1AntiemeticsIBA
06/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2014
1Carboplatin (JM8)FDA LinkGeneric
06/2014
1AntibodiesIBA
11/2012
1FlagellinIBA
11/2012
1Toll-Like Receptor 5IBA
11/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
06/2012
1CholesterolIBA
06/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2010
1E-SelectinIBA
10/2009
1Aluminum Hydroxide (Algeldrate)FDA Link
10/2009
1InterleukinsIBA
04/2009
1Risperidone (Risperdal Consta)FDA LinkGeneric
01/2009
1Nerve Growth Factors (Neurotrophins)IBA
01/2009
1Olanzapine (Zyprexa)FDA Link
06/2008
1MethoxyhydroxyphenylglycolIBA
04/2008
1Biomarkers (Surrogate Marker)IBA
04/2008
1Protein CIBA
02/2008
1Surface-Active Agents (Surfactants)IBA
02/2008
1PrionsIBA
08/2007
1Interleukin-4 (Interleukin 4)IBA
12/2006
1ChemokinesIBA
12/2006
1Chemokine CCL19IBA
12/2006
1Chemotactic FactorsIBA
12/2006
1Chemokine CCL21IBA
12/2006
1LithiumIBA
08/2006
1EndotoxinsIBA
05/2006
1Coloring Agents (Dyes)IBA
01/2005
1LipidsIBA
01/2005
1AcidsIBA
01/2005
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2004
1Pharmaceutical PreparationsIBA
11/2004
1GABA-A Receptors (GABA(A) Receptor)IBA
05/2003
1Radioisotopes (Radionuclides)IBA
11/2002
1SteroidsIBA
09/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2002
1CD40 Ligand (CD40L)IBA
07/2002
1Dantrolene (Dantrium)FDA LinkGeneric
06/2002

Therapy/Procedure

6Therapeutics
01/2021 - 06/2002
1Physical Therapy Modalities (Physical Therapy Technique)
11/2019
1Drug Therapy (Chemotherapy)
06/2014
1Therapeutic Embolization
07/2011
1Intraperitoneal Injections
10/2009